Check out your Company Bowl for anonymous work chats.
This Black History Month we are celebrating the diversity of talent across the Wellcome Genome Campus. For this profile, we spoke to Alice Matimba, Global Training Manager at Wellcome Connecting Science. The Global Training programme is building capacity in biomedicine for research and healthcare communities in Latin America, the Caribbean, Africa and Asia. Hands on, practical courses are run for biomedical research scientists and healthcare professionals, covering everything from drug discovery to epidemiological surveillance of pathogens. Alice speaks about her career, the challenges faced by African scientists, the importance of diversity in genomics and her hopes for building capacity for science around the world.
Talent in Diversity Over this year’s Black History Month, we are celebrating the diversity of talent here at the Sanger Institute. We have talks events and talks happening across the Wellcome Genome Campus. Here, three of our scientists, Tapoka, John and Tobi reflect on their paths into research and why diversity in science is so important.
Wellcome Sanger Institute recognised as Charity Times finalist for outstanding contribution to pandemic response Staff praised for dedication and excellence as they work to sequence coronavirus genomes, helping to shape the pandemic response. On 9th September 2021, the Wellcome Sanger Institute was recognised for its outstanding service – as a finalist in the annual Charity Times awards. The Institute was a finalist in the ‘Charity of the Year’ category for organisations with an income over £10 million. Staff were credited by the judges for their dedication, hard work and excellence over the past year as they worked to sequence the genomes of hundreds of thousands of coronavirus samples. In early March 2020, the Sanger Institute helped found the COVID-19 Genomics UK Consortium (COG-UK). This partnership of NHS and academic organisations working together with UK Public Health Agencies was built in a matter of weeks. The Sanger Institute, with its world-leading facilities, became the genome sequencing hub for the national consortium.
As the sequencing hub of the COVID-19 Genomics UK Consortium (COG-UK), the Sanger Institute is sequencing the genomes of coronavirus samples from across the country. We are often asked questions about how many genomes we sequence, how quickly, and how the data are being used. Below is a snapshot on some of the key numbers, which is updated weekly*. As of 15/02/2021, we have sequenced 163,159 coronavirus genomes. The whole of the UK has sequenced 292,711**. All are freely available for analysis via COG-UK, ENA and GISAID. Across the globe, there are a total of 584,136 sequences available for public analysis***.
We have now started a phased return of more researchers, technicians and scientists returning to work. For more information about how we will be conducting recruitment including interviews, and implementing start dates please contact recruit@sanger.ac.uk
We are delighted to announce that we have been awarded Athena SWAN Silver Award for our commitment to advancing women’s careers in science and progressing equality.
